Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer

European Radiology

Volumn 21, Issue 2, 2011, Pages 274-280

  Gillies, R S ^a   Middleton, M R ^a   Maynard, N D ^a   Bradley, K M ^a   Gleeson, F V ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Oesophageal cancer; PET CT; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79951959785     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1943-z     Document Type: Article

References (23)

1. EP van Vliet MH Heijenbrok-Kal MG Hunink, et al. 2008 Staging investigations for oesophageal cancer: a meta-analysis Br J Cancer 98 547 557 10.1038/sj.bjc.6604200 18212745 (Pubitemid 351214529)
2. PA Heeren PL Jager F Bongaerts, et al. 2004 Detection of distant metastases in esophageal cancer with (18)F-FDG PET J Nucl Med 45 980 987 15181133 (Pubitemid 47611685)
3. S Gananadha EJ Hazebroek S Leibman, et al. 2008 The utility of FDG-PET in the preoperative staging of esophageal cancer Dis Esophagus 21 389 394 1:STN:280:DC%2BD1M%2FlsFemtQ%3D%3D 10.1111/j.1442-2050.2007.00802.x 19125791
4. HL van Westreenen M Westerterp GW Sloof, et al. 2007 Limited additional value of positron emission tomography in staging oesophageal cancer Br J Surg 94 1515 1520 10.1002/bjs.5708 17902092 (Pubitemid 350275631)
5. R Bar-Shalom L Guralnik M Tsalic, et al. 2005 The additional value of PET/CT over PET in FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32 918 924 10.1007/s00259-005-1795-y 15838691 (Pubitemid 41205662)
6. S Yuan Y Yu KS Chao, et al. 2006 Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer J Nucl Med 47 1255 1259 16883002 (Pubitemid 47544876)
7. RG Berrisford WL Wong D Day, et al. 2008 The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team Eur J Cardiothorac Surg 33 1112 1116 10.1016/j.ejcts.2008.01.055 18328726
8. HM Salahudeen A Balan K Naik, et al. 2008 Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma Clin Radiol 63 765 773 1:STN:280:DC%2BD1czos1Oiuw%3D%3D 10.1016/j.crad.2008.02.002 18555034
9. H Kato T Miyazaki M Nakajima, et al. 2005 The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma Cancer 103 148 156 10.1002/cncr.20724 15558794 (Pubitemid 39665468)
10. T Lerut P Flamen N Ectors, et al. 2000 Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy Ann Surg 232 743 752 1:STN:280: DC%2BD3M%2FltVyntA%3D%3D 10.1097/00000658-200012000-00003 11088069
11. P Flamen A Lerut E Van Cutsem, et al. 2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18 3202 3210 1:STN:280:DC%2BD3cvotlentw%3D%3D 10986052
12. JD Luketich PR Schauer CC Meltzer, et al. 1997 Role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 765 769 1:STN:280:DyaK2svlt1Krsg%3D%3D 10.1016/S0003-4975(97)00624-3 9307471 (Pubitemid 27435689)
13. M Okada T Murakami S Kumano, et al. 2009 Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer Ann Nucl Med 23 73 80 10.1007/s12149-008-0209-1 19205841
14. F Noble D Bailey K Tung JP Byrne 2009 Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study Clin Radiol 64 699 705 1:STN:280:DC%2BD1MvhsVSqtQ%3D%3D 10.1016/j.crad.2009.03.003 19520214
15. JB Roedl DV Sahani RR Colen, et al. 2008 Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer Eur Radiol 18 2833 2840 10.1007/s00330-008-1078-7 18651155
16. TC Kwee T Takahara R Ochiai, et al. 2008 Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology Eur Radiol 18 1937 1952 10.1007/s00330-008-0968-z 18446344
17. A Sakurada T Takahara TC Kwee, et al. 2009 Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer Eur Radiol 19 1461 1469 10.1007/s00330-008-1291-4 19172278
18. BF Meyers RJ Downey PA Decker, et al. 2007 The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial J Thorac Cardiovasc Surg 133 738 745 10.1016/j.jtcvs.2006.09.079 17320575 (Pubitemid 46274752)
19. M Westerterp GW Sloof OS Hoekstra, et al. 2008 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome J Cancer Res Clin Oncol 134 227 236 10.1007/s00432-007-0275-0 17653575 (Pubitemid 350234068)
20. H Kato J Takita T Miyazaki, et al. 2003 Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma Anticancer Res 23 3263 3272 1:CAS:528:DC%2BD3sXntVChu7c%3D 12926062 (Pubitemid 36975422)
21. HL van Westreenen JT Plukker DC Cobben, et al. 2005 Prognostic value of the standardized uptake value in esophageal cancer AJR Am J Roentgenol 185 436 440 16037517
22. D Hong S Lunagomez EE Kim, et al. 2005 Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma Cancer 104 1620 1626 10.1002/cncr.21356 16118804 (Pubitemid 41437424)
23. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg 82 391 394 10.1016/j.athoracsur.2006.03.045 16863735 discussion 394-395 (Pubitemid 44080040)